Related Experiment Video
Updated: Aug 28, 2025

13:35
Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
Published on: May 17, 2024
2.9K
Is repeat breast conservation possible for small ipsilateral breast cancer recurrence?
Yong Li1,2, Wei-Wen Li1, Lin Yuan1,2
1Department of Breast, Jiangmen Central Hospital, Jiangmen City, Guangdong Province, People's Republic of China.
Cancer
|September 21, 2022
Summary
Repeat breast-conserving surgery (re-BCS) for small ipsilateral breast tumor recurrence (IBTR) showed worse survival than mastectomy. However, estrogen receptor-positive status and radiation therapy may improve outcomes for re-BCS candidates.
Area of Science:
- Oncology
- Surgical Oncology
- Breast Cancer Research
Background:
- Ipsilateral breast tumor recurrence (IBTR) after breast-conserving surgery (BCS) often involves small tumors.
- While mastectomy is recommended by some guidelines, repeat breast-conserving surgery (re-BCS) is preferred by many patients.
- This study evaluates re-BCS versus mastectomy for small IBTR prognosis.
Purpose of the Study:
- To compare the oncological outcomes of re-BCS and mastectomy in patients with small IBTR.
- To identify patient subgroups who may be suitable candidates for re-BCS.
Main Methods:
- Analysis of a population-based cohort from the Surveillance, Epidemiology, and End Results database (1999-2015).
- Inclusion of 3648 patients with small IBTR, comparing outcomes between mastectomy (n=2831) and re-BCS (n=817).
- Utilized multivariable Cox regression and propensity score matching to assess overall survival (OS) and breast cancer-specific survival (BCSS).
Main Results:
- Re-BCS was associated with significantly worse OS (HR 1.342) and BCSS (HR 1.454) compared to mastectomy.
- Omission of radiation after re-BCS correlated with poorer survival, particularly in estrogen receptor (ER)-negative IBTR.
- No significant survival differences were found between re-BCS with radiation and mastectomy; surgical approach was not an independent factor in ER-positive IBTR.
Conclusions:
- Re-BCS for small IBTR warrants careful consideration due to potential survival disadvantages.
- Estrogen receptor (ER) status is a critical factor in selecting patients for re-BCS.
- Radiation therapy following re-BCS may enhance oncological safety and improve survival outcomes.

